Form D Explorer

Inspect source fieldsReport a record issue

Form D — ELIXIRGEN THERAPEUTICS, INC.

0001744333-25-000002 · filed Apr 9, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$3,600,000
Reported amount sold
$3,600,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
ELIXIRGEN THERAPEUTICS, INC.
CIK
1744333
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
855 N. WOLFE ST.
BALTIMORE, Maryland 21205
Phone
443-451-5300

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗